Janus Henderson Group PLC Dyne Therapeutics, Inc. Put Options Transaction History
Janus Henderson Group PLC
- $188 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DYN
# of Institutions
213Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$111 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$102 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$92.4 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$87.9 Million2.43% of portfolio
-
Fcpm Iii Services B.V. Naarden, P75.46MShares$75.3 Million21.73% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $713M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...